{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T02:28:36Z","timestamp":1705890516720},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1758-5996-6-48","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T11:01:40Z","timestamp":1396263700000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study"],"prefix":"10.1186","volume":"6","author":[{"given":"Noriko","family":"Ihana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuko","family":"Yamamoto-Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Noto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kakei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s13340-010-0006-7","volume":"1","author":"The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus","year":"2010","unstructured":"The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010, 1: 2-20. 10.1007\/s13340-010-0006-7.","journal-title":"Diabetol Int"},{"key":"416_CR2","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/dme.1996.13.s6.109","volume":"13","author":"K Kosaka","year":"1996","unstructured":"Kosaka K, Kuzuya T, Hagura R, Yoshinaga H: Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med. 1996, 13: S109-S119.","journal-title":"Diabet Med"},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s13340-011-0024-0","volume":"2","author":"R Yamamoto-Honda","year":"2011","unstructured":"Yamamoto-Honda R, Osame K, Kitazato H, Shinkai-Goromaru M, Isogawa A, Yoshida Y, Kawzu S, Akanuma Y, Noda M: Insulin secretion and insulin sensitivity in Japanese patients with Type 2 diabetes: a cross-sectional study comparing the homeostasis model assessment-2 (HOMA2) indexes and indexes derived from the oral glucose tolerance test. Diabetology Int. 2011, 2: 72-78. 10.1007\/s13340-011-0024-0.","journal-title":"Diabetology Int"},{"key":"416_CR4","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa075392","volume":"357","author":"RR Holman","year":"2007","unstructured":"Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, 4-T Study Group: Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. N Engl J Med. 2007, 357: 1716-1730. 10.1056\/NEJMoa075392.","journal-title":"N Engl J Med"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","volume":"371","author":"RG Bretzel","year":"2008","unstructured":"Bretzel RG, Nuber U, Landgraf W, Owens DR, Brandley C, Linn T, Bretzel A, Nuber U, Landgraf W, Owens DR, Brandley C, Linn T: Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. Lancet. 2008, 371: 1073-1084. 10.1016\/S0140-6736(08)60485-7.","journal-title":"Lancet"},{"issue":"4","key":"416_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2337\/diacare.25.4.737","volume":"25","author":"L Monnier","year":"2002","unstructured":"Monnier L, Colette C, Rabasa-Lhoret R, Lapinski H, Caubel C, Avignon A, Boniface H: Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care. 2002, 25 (4): 737-741. 10.2337\/diacare.25.4.737.","journal-title":"Diabetes Care"},{"issue":"5","key":"416_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1507\/endocrj.K08E-071","volume":"55","author":"R Yamamoto-Honda","year":"2008","unstructured":"Yamamoto-Honda R, Kitazato H, Hashimoto S, Takahashi Y, Yoshida Y, Hasegawa C, Akanuma Y, Noda M: Distribution of blood glucose and correlation between blood glucose and hemoglobin A1c levels in diabetic outpatients. Endocr J. 2008, 55 (5): 913-923. 10.1507\/endocrj.K08E-071.","journal-title":"Endocr J"},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archinte.161.3.397","volume":"161","author":"DECODE Study Group, on behalf of the European Diabetes Epidemiology Group","year":"2001","unstructured":"DECODE Study Group, on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001, 161: 397-405.","journal-title":"Arch Intern Med"},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F, The ADVANCE Collaborative Group: Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2008, 358: 2560-2572.","journal-title":"N Engl J Med"},{"key":"416_CR10","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1001\/archinte.164.19.2090","volume":"164","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J, for the International Prandial Glucose Regulation (PGR) Study Group: Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004, 164: 2090-2095. 10.1001\/archinte.164.19.2090.","journal-title":"Arch Intern Med"},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.2337\/dc10-2414","volume":"34","author":"F Cavalot","year":"2011","unstructured":"Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P, Anfossi G, Trovati M: Postprandial blood glucose predicts cardiovascular events and all-cause mortality in Type2 Diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga diabetes study. Diabetes Care. 2011, 34: 2237-2243. 10.2337\/dc10-2414.","journal-title":"Diabetes Care"},{"key":"416_CR12","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.2337\/diacare.28.11.2806","volume":"28","author":"T Shiraiwa","year":"2005","unstructured":"Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y: Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care. 2005, 28: 2806-2807. 10.2337\/diacare.28.11.2806.","journal-title":"Diabetes Care"},{"key":"416_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1464-5491.2010.03223.x","volume":"28","author":"MV Chittari","year":"2011","unstructured":"Chittari MV, MacTernan P, Bawazeer N, Constantinides K, Ciotola M, O\u2019Hare JP, Kumar S, Ceriello A: Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes. Diabet Med. 2011, 28: 450-454. 10.1111\/j.1464-5491.2010.03223.x.","journal-title":"Diabet Med"},{"key":"416_CR14","doi-asserted-by":"publisher","first-page":"f4533","DOI":"10.1136\/bmj.f4533","volume":"347","author":"A Goto","year":"2013","unstructured":"Goto A, Arah OA, Goto M, Terauchi Y, Noda M: Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013, 347: f4533-10.1136\/bmj.f4533.","journal-title":"BMJ"},{"issue":"1","key":"416_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/dc13-0701","volume":"37","author":"T Tsujimoto","year":"2014","unstructured":"Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M: Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease during Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients. Diabetes Care. 2014, 37 (1): 217-25. 10.2337\/dc13-0701.","journal-title":"Diabetes Care"},{"issue":"Supplement","key":"416_CR16","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association: Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013, 36 (Supplement): S11-S66.","journal-title":"Diabetes Care"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.0954-6820.1965.tb01810.x","volume":"177","author":"J Schichtkrull","year":"1965","unstructured":"Schichtkrull J, Munck O, Jersild M: The M-Value, an index of Blood-Sugar Control in Diabetics. Acta Med Scand. 1965, 177: 95-102.","journal-title":"Acta Med Scand"},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-979895","volume":"27","author":"JM W\u00f3jcicki","year":"1995","unstructured":"W\u00f3jcicki JM: Mathematical descriptions of the glucose control in diabetes therapy. Analysis of the Schlichtkrull \u201cM\u201d-value. Horm Metab Res. 1995, 27: 1-5. 10.1055\/s-2007-979895.","journal-title":"Horm Metab Res"},{"issue":"9","key":"416_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2337\/diab.19.9.644","volume":"19","author":"FJ Service","year":"1970","unstructured":"Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, William FT: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970, 19 (9): 644-655.","journal-title":"Diabetes"},{"key":"416_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","volume":"49","author":"H Yuki-J\u00e4rvinen","year":"2006","unstructured":"Yuki-J\u00e4rvinen H, Kauppinen-M\u00e4kelin R, Tiikkainen M, V\u00e4h\u00e4talo M, Virtamo H, Nikkil\u00e4 K, Tulokas T, Hulme S, Hardy K, McNulty S, H\u00e4nninen J, Lev\u00e4nen H, Lahdenper\u00e4 S, Lehtonen R, Ryysy L: Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 2006, 49: 442-451. 10.1007\/s00125-005-0132-0.","journal-title":"Diabetologia"},{"key":"416_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","volume":"51","author":"J Rosenstock","year":"2008","unstructured":"Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G: A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administrated as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia. 2008, 51: 408-416. 10.1007\/s00125-007-0911-x.","journal-title":"Diabetologia"},{"key":"416_CR22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1463-1326.2011.01412.x","volume":"13","author":"V Fonseca","year":"2011","unstructured":"Fonseca V, Gill J, Zhou R, Leahy J: An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycemic control and hypoglycemia. Diabetes, Obesity and Metabolism. 2011, 13: 814-822. 10.1111\/j.1463-1326.2011.01412.x.","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"416_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1475-2840-10-115","volume":"10","author":"M Kishimoto","year":"2011","unstructured":"Kishimoto M, Noda M: A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers. Cardiovasc Diabetol. 2011, 10: 115-10.1186\/1475-2840-10-115.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"416_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1463-1326.2002.00219.x","volume":"4","author":"A Lee","year":"2002","unstructured":"Lee A, Patric P, Wishart J, Horowitz M, Morley JE: The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab. 2002, 4 (5): 329-335. 10.1046\/j.1463-1326.2002.00219.x.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"416_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0014-2999(01)01412-1","volume":"431","author":"Y Sunaga","year":"2001","unstructured":"Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S: The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K\u2009+\u2009channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol. 2001, 431 (1): 199-225.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"416_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1385\/ENDO:29:2:309","volume":"29","author":"Y Mori","year":"2006","unstructured":"Mori Y, Ojima K, Fuujimori Y, Aoyagi I, Kusama H, Yamazaki Y, Kojima M, Shibata N, Itoh Y, Tajima N: Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats. Endocrine. 2006, 29 (2): 309-15. 10.1385\/ENDO:29:2:309.","journal-title":"Endocrine"},{"issue":"3","key":"416_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diabres.2011.01.022","volume":"92","author":"MK Kim","year":"2011","unstructured":"Kim MK, Suk JH, Kwon MJ, Chung HS, Yoon CS, Jun HJ, Ko JH, Kim TK, Lee SH, Oh MK, Rhee BD, Park JH: Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes. Diabetes Res Clin Pract. 2011, 92 (3): 322-328. 10.1016\/j.diabres.2011.01.022.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"416_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1507\/endocrj.53.67","volume":"53","author":"T Yoshihara","year":"2006","unstructured":"Yoshihara T, Kumashiro N, Kanazawa Y, Mita T, Sakurai Y, Kawai J, Abe M, Motojima K, Hara K, Yamazaki Y, Kanazawa A, Miwa S, Sato F, Kanno R, Shimizu T, Sakai K, Uchino H, Watada H, Tanaka Y, Kawamori R, Hirose T: Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus. Endocr J. 2006, 53 (1): 67-72. 10.1507\/endocrj.53.67.","journal-title":"Endocr J"},{"issue":"1","key":"416_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1507\/endocrj.K06-153","volume":"54","author":"N Kumashiro","year":"2007","unstructured":"Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T: Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study. Endocr J. 2007, 54 (1): 163-166. 10.1507\/endocrj.K06-153.","journal-title":"Endocr J"},{"issue":"12","key":"416_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1507\/endocrj.EJ12-0220","volume":"59","author":"M Takahara","year":"2013","unstructured":"Takahara M, Shiraiwa T, Kaneto H, Katakami N, Matsuoka TA, Shimomura I: Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy. Endocr J. 2013, 59 (12): 1131-1136.","journal-title":"Endocr J"},{"key":"416_CR31","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/dc09-2191","volume":"33","author":"S Arnolds","year":"2010","unstructured":"Arnolds S, Dellweg S, Clair J, Dain MP, Nauck MA, Rave K, Kapitza C: Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study. Diabetes Care. 2010, 33: 1509-1515. 10.2337\/dc09-2191.","journal-title":"Diabetes Care"},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13300-012-0011-x","volume":"3","author":"M Kishimoto","year":"2012","unstructured":"Kishimoto M, Noda M: Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes. Diabetes Ther. 2012, 3: 11-","journal-title":"Diabetes Ther"},{"key":"416_CR33","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association: Standards of Medical Care in Diabetes-2014. Diabetes Care. 2014, 37: S14-80.","journal-title":"Diabetes Care"},{"issue":"6","key":"416_CR34","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD): Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012, 35 (6): 1364-79. 10.2337\/dc12-0413.","journal-title":"Diabetes Care"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-5996-6-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:57:29Z","timestamp":1630583849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/1758-5996-6-48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1186\/1758-5996-6-48","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]},"assertion":[{"value":"24 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}